Results 331 to 340 of about 3,441,901 (408)
Comparative Analysis of Pure VWF and VWF/FVIII Complex in Orthopedic Surgery for Type 2B von Willebrand Disease. [PDF]
Chamouni P+3 more
europepmc +1 more source
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi+3 more
wiley +1 more source
Thalidomide Treatment for Thrombocytopenia Secondary to Hypersplenism in Children with Transfusion-Dependent β-Thalassemia: A Case Series. [PDF]
Gong X, Xiao J, Kong W, Liu X, Yang K.
europepmc +1 more source
Reference intervals of haematological indices for young adults with sickle cell anaemia in Southwestern Nigeria. [PDF]
Asafa MA+7 more
europepmc +1 more source
A case of hemichorea-hemiballismus secondary to a subacute hemorrhage in a patient with essential thrombocythemia: a case report. [PDF]
Harrison A, Zhang T, Batra G.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood Coagulation & Fibrinolysis, 2015
Thrombocytes or platelets are anucleated cells derived from megakaryocytes by process of megakaryopoiesis, with maturation time of 4-5 days. They are small and discoid in shape with size ranging from 2 to 4 μm. The platelet concentration in blood varies between 150, 000 and 400, 000 cells/μl of blood.
Vani Rajashekaraiah, Manasa Krishnegowda
openaire +5 more sources
Thrombocytes or platelets are anucleated cells derived from megakaryocytes by process of megakaryopoiesis, with maturation time of 4-5 days. They are small and discoid in shape with size ranging from 2 to 4 μm. The platelet concentration in blood varies between 150, 000 and 400, 000 cells/μl of blood.
Vani Rajashekaraiah, Manasa Krishnegowda
openaire +5 more sources
Migraine Is Not a Platelet Disorder
Headache: The Journal of Head and Face Pain, 1985SYNOPSISThe platelet theory of migraine causation predicts that drugs inhibiting platelet activation will be effective in migraine prevention, but the literature indicates that this is only partly the case. Conversely, therapy achieving clinical benefit should be associated with reduced platelet activity. To test this concept, the β‐adrenergic blockers
Rajiv Joseph+2 more
openaire +4 more sources
Pediatric and Developmental Pathology, 2019
Germline mutations in RUNX1 result in autosomal dominant familial platelet disorder with associated myeloid malignancy (FPDMM). To characterize the hematopathologic features associated with a germline RUNX1 mutation, we reviewed a total of 42 bone marrow
Karen M. Chisholm+8 more
semanticscholar +1 more source
Germline mutations in RUNX1 result in autosomal dominant familial platelet disorder with associated myeloid malignancy (FPDMM). To characterize the hematopathologic features associated with a germline RUNX1 mutation, we reviewed a total of 42 bone marrow
Karen M. Chisholm+8 more
semanticscholar +1 more source